Calprotectin reveals distinct innate immune signatures in NMOSD, MOGAD, and multiple sclerosis.

Saved in:
Bibliographic Details
Title: Calprotectin reveals distinct innate immune signatures in NMOSD, MOGAD, and multiple sclerosis.
Authors: Johnsson M; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden/Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Neurology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden. Electronic address: magnus.johnsson@neuro.gu.se., Lycke J; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden/Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Neurology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden., Novakova L; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden/Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Neurology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden., Rosenstein I; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden/Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Neurology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden., Hafsteinsdottir B; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden/Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Neurology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden., Malmeström C; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden/Sahlgrenska University Hospital, Gothenburg, Sweden; Laboratory for Clinical Immunology, Clinical immunology and transfusion medicine, Sahlgrenska University Hospital, Gothenburg, Sweden., Axelsson M; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden/Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Neurology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
Source: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2026 May; Vol. 109, pp. 107163. Date of Electronic Publication: 2026 Mar 26.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2211-0356
DOI:10.1016/j.msard.2026.107163